Phase 1/2 Dose Confirmation Study of FLT180a in Hemophilia B

NCT05164471 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
6
Enrollment
INDUSTRY
Sponsor class

Stopped Freeline has decided to pause development of FLT180a for business priorities

Conditions

Interventions

Sponsor

Spur Therapeutics